GERMANTOWN, Md., Jan. 27, 2016 /PRNewswire/ -- Neuralstem, Inc. (Nasdaq: CUR), a biopharmaceutical company using neural stem cell technology to develop regenerative therapies and small molecule ...
GERMANTOWN, Md., April 12, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell ...
- NSI-566 shown to have restorative function in primate paralysis model - - NSI-566 transplantation resulted in measurable improvement in forelimb function - GERMANTOWN, Md., March 13, 2018 (GLOBE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results